TCRX · ISSUER CIK 1783328
TScan Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 TScan Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:46 | Oct 1, 2026 | TCRX | Chief Executive Officer, Director | A · Grant | — | +1,000,000 | 1,049,767 | +2009% | — | ||
| Oct 2, 202616:45 | Oct 1, 2026 | TCRX | See Remarks | A · Grant | — | +300,000 | 304,716 | +6361% | — |